Mölnlycke Health Care China has set up the MHC-Guangzhou Red Cross Hospital Wound & Scar Treatment Centre (The Guangzhou Centre), with the Burn, and Plastic & Reconstructive Surgery Department of the Guangzhou Red Cross Hospital.
The Guangzhou Centre was inaugurated by His Honourable, Director Wen Waiquan, Medical Affairs Department, Guangdong Provincial Health Bureau, and His Honourable, Lennart Nilsson, Swedish Trade Counsellor for Southern China, at the Guanghzou Red Cross Hospital in Guangzhou, Guangdong Province, China on Saturday, 22 January 2011. The event was attended by senior provincial government officials, national and provincial key opinion leaders in the field of burn and wound therapy.
The Guangzhou Centre will be the first MHC Wound & Scar Treatment Centre in Southern China and modelled after the Mölnlycke Health Care-Peking Union Medical College Hospital Best Practice Wound & Scar Treatment Reference Unit inaugurated by His Excellency Mr. Lars Fresden, Swedish Ambassador to China on 17 September 2010 in Beijing.
The MHC Wound & Scar Treatment Centres in China are supported by Mölnlycke Health Care Wound Care Division to promote best practice in wound and scar therapy, serve as a model of its kind in exchange of KOLs within and out-side of China and as a learning centre for clinicians in advanced wound care.
MHC China is a wholly owned branch of Mölnlycke Health Care AB, located in Gothenburg, Sweden, a leading research and development based medical device company specializing in advanced wound care and surgical solutions founded in 1849. MHC China has become a leading wound care solution provider to teaching and general hospitals in the top 30 cities in China. It has also been recognized as the leader in helping hospitals to set-up Wound & Scar Treatment Centres, and provides residential training to chiefs and directors of burn, and plastic & reconstructive surgery departments in key medical centres in Asia Pacific, Europe and North America.
Guangzhou Red Cross Hospital is a 1,000-bed teaching hospital affiliated with Jinan University Medical College founded in 1904. It also serves as the National Centre in Clinical Pharmacy in adverse drug reactions and clinical research. The hospital undertakes clinical research, education and training, and provides medical treatment for both in- and out- patients. The Burn, and Plastic & Reconstructive Surgery Department is the designated Clinical Research Centre of the State Food & Drug Administration and has 80-beds dedicated to clinical teaching and is the largest burn centre in southern China supported by 61 clinicians including 24 qualified surgeons.